Case Report: Rare Multidrug-Resistant Enterobacter Cloacae Complicated by Invasive Pulmonary Aspergillosis in an Elderly ...
Introduction Osimertinib is the preferred first-line therapy for EGFR-mutated advanced non-small cell lung cancer (NSCLC), offering superior efficacy and central nervous system penetration compared to earlier-generation TKIs.1 Patients with advanced NSCLC …